Fibrogenesis, novel lessons from animal models

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Seminars in Immunopathology

• Publication date

  2015-07-04

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00281-015-0510-8PMID 26141608
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• B cell activating factor is central to bleomycin- and IL-17-mediated experimental pulmonary fibrosis.

  2015cited by this paper
• Editorial: Fate of Fat Tissue Adipocytes: Do They Transform Into Myofibroblasts in Scleroderma?

  2015cited by this paper
• Stimulators of soluble guanylate cyclase (sGC) inhibit experimental skin fibrosis of different aetiologies

  2015cited by this paper
• Myofibroblasts in Murine Cutaneous Fibrosis Originate From Adiponectin‐Positive Intradermal Progenitors

  2015cited by this paper
• Cardiomyopathy in Murine Models of Systemic Sclerosis

  2015cited by this paper
• Tribbles homologue 3 stimulates canonical TGF-β signalling to regulate fibroblast activation and tissue fibrosis

  2015cited by this paper
• Amelioration of Tissue Fibrosis by Toll‐like Receptor 4 Knockout in Murine Models of Systemic Sclerosis

  2015cited by this paper
• Riociguat for the treatment of pulmonary arterial hypertension: a long-term extension study (PATENT-2)

  2015cited by this paper
• Nintedanib inhibits fibroblast activation and ameliorates fibrosis in preclinical models of systemic sclerosis

  2015cited by this paper
• Secreted frizzled related proteins inhibit fibrosis in vitro but appear redundant in vivo

  2014cited by this paper
• Stimulation of the soluble guanylate cyclase (sGC) inhibits fibrosis by blocking non-canonical TGFβ signalling

  2014cited by this paper
• Combined inhibition of morphogen pathways demonstrates additive antifibrotic effects and improved tolerability

  2014cited by this paper
• Skin Progenitor Cells Contribute to Bleomycin‐Induced Skin Fibrosis

  2014cited by this paper
• Development of an Autoimmune Syndrome Affecting the Skin and Internal Organs in P‐Selectin Glycoprotein Ligand 1 Leukocyte Receptor–Deficient Mice

  2014cited by this paper
• Riociguat for the treatment of pulmonary arterial hypertension.

  2013cited by this paper
• Inactivation of evenness interrupted (EVI) reduces experimental fibrosis by combined inhibition of canonical and non-canonical Wnt signalling

  2013cited by this paper
• Blockade of canonical Wnt signalling ameliorates experimental dermal fibrosis

  2013cited by this paper
• Levels of target activation predict antifibrotic responses to tyrosine kinase inhibitors

  2013cited by this paper
• Heat shock protein 90 (Hsp90) inhibition targets canonical TGF-β signalling to prevent fibrosis

  2013cited by this paper
• The Wnt antagonists DKK1 and SFRP1 are downregulated by promoter hypermethylation in systemic sclerosis

  2013cited by this paper
• Inactivation of urokinase-type plasminogen activator receptor (uPAR) gene induces dermal and pulmonary fibrosis and peripheral microvasculopathy in mice: a new model of experimental scleroderma?

  2013cited by this paper
• Simvastatin attenuates the development of pulmonary and cutaneous fibrosis in a murine model of systemic sclerosis.

  2013cited by this paper
• Toll-like receptor 4 signaling augments transforming growth factor-β responses: a novel mechanism for maintaining and amplifying fibrosis in scleroderma.

  2013cited by this paper
• Vascular endothelial growth factor aggravates fibrosis and vasculopathy in experimental models of systemic sclerosis

  2013cited by this paper
• CD109 overexpression ameliorates skin fibrosis in a mouse model of bleomycin-induced scleroderma.

  2013cited by this paper
• JAK-2 as a novel mediator of the profibrotic effects of transforming growth factor β in systemic sclerosis.

  2012cited by this paper
• Fra-2 transgenic mice as a novel model of pulmonary hypertension associated with systemic sclerosis

  2012cited by this paper
• β-catenin is a central mediator of pro-fibrotic Wnt signaling in systemic sclerosis

  2012cited by this paper
• Critical role of the adhesion receptor DNAX accessory molecule-1 (DNAM-1) in the development of inflammation-driven dermal fibrosis in a mouse model of systemic sclerosis

  2012cited by this paper
• Inactivation of tankyrases reduces experimental fibrosis by inhibiting canonical Wnt signalling

  2012cited by this paper
• Morphogen pathways as molecular targets for the treatment of fibrosis in systemic sclerosis

  2012cited by this paper
• Reactive oxygen species-mediated killing of activated fibroblasts by arsenic trioxide ameliorates fibrosis in a murine model of systemic sclerosis.

  2012cited by this paper
• Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosis

  2012cited by this paper
• Wnt/β-catenin signaling and disease.

  2012cited by this paper
• Inhibition of H3K27 histone trimethylation activates fibroblasts and induces fibrosis

  2012influential reference
• The organotelluride catalyst (PHTE)₂NQ prevents HOCl-induced systemic sclerosis in mouse.

  2012cited by this paper
• Angiogenic cytokines and growth factors in systemic sclerosis.

  2011cited by this paper
• B-Cell Depletion Therapy in Systemic Sclerosis: Experimental Rationale and Update on Clinical Evidence

  2011cited by this paper
• Canonical Wnt signaling induces skin fibrosis and subcutaneous lipoatrophy: a novel mouse model for scleroderma?

  2011cited by this paper
• Platelet-derived serotonin links vascular disease and tissue fibrosis

  2011cited by this paper
• Inhibition of glycogen synthase kinase 3β induces dermal fibrosis by activation of the canonical Wnt pathway

  2011cited by this paper
• An update on an immune system that goes awry in systemic sclerosis

  2011cited by this paper
• A genetic variation located in the promoter region of the UPAR (CD87) gene is associated with the vascular complications of systemic sclerosis.

  2011cited by this paper
• Inhibition of Notch signaling prevents experimental fibrosis and induces regression of established fibrosis.

  2011cited by this paper
• Notch signalling regulates fibroblast activation and collagen release in systemic sclerosis

  2011cited by this paper
• Nuclear β-catenin is increased in systemic sclerosis pulmonary fibrosis and promotes lung fibroblast migration and proliferation.

  2011cited by this paper
• Jun N-terminal kinase as a potential molecular target for prevention and treatment of dermal fibrosis

  2011cited by this paper
• Role of endothelial-mesenchymal transition (EndoMT) in the pathogenesis of fibrotic disorders.

  2011cited by this paper
• Imatinib treatment for idiopathic pulmonary fibrosis: Randomized placebo-controlled trial results.

  2010cited by this paper
• Inhibition of Wnt/β-catenin/CREB binding protein (CBP) signaling reverses pulmonary fibrosis

  2010cited by this paper
• Endothelial Fli1 deficiency impairs vascular homeostasis: a role in scleroderma vasculopathy.

  2010cited by this paper
• Distinct evolution of TLR-mediated dendritic cell cytokine secretion in patients with limited and diffuse cutaneous systemic sclerosis

  2010cited by this paper
• Inactivation of the cannabinoid receptor CB1 prevents leukocyte infiltration and experimental fibrosis.

  2010cited by this paper
• Randomized, prospective, placebo-controlled trial of bosentan in interstitial lung disease secondary to systemic sclerosis.

  2010cited by this paper
• Scleroderma.

  2009cited by this paper
• Selective Oxidation of DNA Topoisomerase 1 Induces Systemic Sclerosis in the Mouse1

  2009influential reference
• Transcription Factor Fos-Related Antigen-2 Induces Progressive Peripheral Vasculopathy in Mice Closely Resembling Human Systemic Sclerosis

  2009cited by this paper
• Development of pulmonary fibrosis through a pathway involving the transcription factor Fra-2/AP-1

  2008cited by this paper
• Transcription Factor Fli1 Regulates Collagen Fibrillogenesis in Mouse Skin

  2008cited by this paper
• Cellular and molecular mechanisms of fibrosis

  2008cited by this paper
• Transforming Growth Factor-β Regulates DNA Binding Activity of Transcription Factor Fli1 by p300/CREB-binding Protein-associated Factor-dependent Acetylation*

  2007cited by this paper
• [Cellular and molecular mechanisms of fibrosis].

  2006cited by this paper
• Association between enhanced type I collagen expression and epigenetic repression of the FLI1 gene in scleroderma fibroblasts.

  2006cited by this paper
• Fli1 and Ets1 Have Distinct Roles in Connective Tissue Growth Factor/CCN2 Gene Regulation and Induction of the Profibrotic Gene Program*

  2006cited by this paper
• Shared expression of phenotypic markers in systemic sclerosis indicates a convergence of pericytes and fibroblasts to a myofibroblast lineage in fibrosis

  2005cited by this paper
• Abnormal natural killer cell function in systemic sclerosis: altered cytokine production and defective killing activity.

  2005cited by this paper
• Nifedipine decreases sVCAM-1 concentrations and oxidative stress in systemic sclerosis but does not affect the concentrations of vascular endothelial growth factor or its soluble receptor 1

  2004cited by this paper
• Uncontrolled Expression of Vascular Endothelial Growth Factor and Its Receptors Leads to Insufficient Skin Angiogenesis in Patients With Systemic Sclerosis

  2004cited by this paper
• Imatinib mesylate inhibits the profibrogenic activity of TGF-beta and prevents bleomycin-mediated lung fibrosis.

  2004cited by this paper
• Epithelial-mesenchymal transition and its implications for fibrosis.

  2003cited by this paper
• Systemic and cell type-specific gene expression patterns in scleroderma skin

  2003cited by this paper
• Persistent down-regulation of Fli1, a suppressor of collagen transcription, in fibrotic scleroderma skin.

  2003cited by this paper
• Oligoclonal T Cell Expansion in the Skin of Patients with Systemic Sclerosis1

  2002cited by this paper
• The emerging problem of oxidative stress and the role of antioxidants in systemic sclerosis.

  2001cited by this paper
• Fli-1 Inhibits Collagen Type I Production in Dermal Fibroblasts via an Sp1-dependent Pathway*

  2001cited by this paper
• Hemorrhage, Impaired Hematopoiesis, and Lethality in Mouse Embryos Carrying a Targeted Disruption of the Fli1Transcription Factor

  2000cited by this paper
• Monocytes of patients wiht systemic sclerosis (scleroderma spontaneously release in vitro increased amounts of superoxide anion.

  1999cited by this paper
• Type 2 helper T-cell predominance and high CD30 expression in systemic sclerosis.

  1997cited by this paper
• Generation and characterization of urokinase receptor-deficient mice.

  1996cited by this paper
• Mononuclear cellular infiltrates in clinically involved skin from patients with systemic sclerosis of recent onset predominantly consist of monocytes/macrophages.

  1995cited by this paper
• Circulating Fibrocytes Define a New Leukocyte Subpopulation That Mediates Tissue Repair

  1994cited by this paper
• Analysis of the DNA-binding and transcriptional activation functions of human Fli-1 protein.

  1993cited by this paper
• Macrophage infiltration in the skin of patients with systemic sclerosis.

  1992cited by this paper
• Identification and mapping of a common proviral integration site Fli-1 in erythroleukemia cells induced by Friend murine leukemia virus.

  1990cited by this paper

• Protein Tyrosine Phosphatase-α Amplifies TGF-β-Dependent Pro-Fibrotic Signaling in Lung Fibroblasts.

  2020cites this paper
• Pilot study of use of laser fluorescence spectroscopy and optical tissue oximetry in the diagnosis and assessment of cicatricial lesions

  2020cites this paper
• Пилотное исследование применения лазерной флюоресцентной спектроскопии и оптической тканевой оксиметрии в диагностике и оценке течения рубцовых поражений кожи

  2020cites this paper
• The Effect of Function-blocking RHAMM Peptides in a Mouse Model of Bleomycin-induced Systemic Sclerosis

  2018cites this paper
• Multiorgan chronic inflammatory hepatobiliary pancreatic murine model deficient in tumor necrosis factor receptors 1 and 2.

  2016cites this paper
• The WNT signalling pathway in systemic sclerosis

  2016cites this paper
• Développement d’un nouveau modèle murin expérimental de sclérodermie

  2016cites this paper